The Facility has contributed to the following publications(2005 - Oct, 2008 )

1. Huang H., Feng J., Famulski J., Rattner J.B., Liu S.T., Kao G.D., Muschel R., Chan G.K.T., T.J. Yen. (2007). Tripin/hSgo2 recruits MCAK to the inner centromere to correct defective kinetochore attachments. J. Cell Biology 17:413-424.
2. Famulski J.K., G.K. Chan. (2007). Aurora B kinase-dependent recruitment of hZW10 and hROD to tension-less kinetochores. Current Biology 17, 2143–2149.
3. Famulski J.K., Vos L.J., Sun X.J. and G.K. Chan. 2008. Stable hZW10 residency at kinetochores, mediated through hZwint-1 interaction, is essential for mitotic checkpoint function. Journal of Cell Biology,180:507-520.
4. Vos L.J., Famulski J.K. & G.K. Chan. 2006. How to build a centromere: from centromeric and pericentromeric chromatin to kinetochore assembly. Biochemistry and Cell Biology 84(4):619–616
5. Damaraju VL, Elwi AN, Hunter C, Carpenter P, Santos C, Barron GM, Sun X, Baldwin SA, Young JD, Mackey JR, Sawyer MB, Cass CE. Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidney. Am J Physiol Renal Physiol. 2007 Jul;293(1):F200-11. Epub 2007 Apr 4.
6. Damaraju D, Damaraju VL, Brun M, Mowles D, Kuzma M, Berendt RC, Sawyer MB, Cass CE. Cytotoxic activities of nucleoside and nucleobase analog drugs in malignant mesothelioma: characterization of a novel nucleobase transport activity. Biochem Pharmacol. 2008 May 15;75(10):1901-11. Epub 2008 Feb 16.
7. Cai J, Damaraju VL, Groulx N, Mowles D, Peng Y, Robins MJ, Cass CE, Gros P. Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells. Cancer Res. 2008 Apr 1;68(7):2349-57. PMID: 18381442 [PubMed - indexed for MEDLINE]
8. Adamia S, Maxwell CA, Pilarski LM. Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer. Curr Drug Targets Cardiovasc Haematol Disord. 2005 Feb;5(1):3-14. .
9. Adamia S, Reiman T, Crainie M, Mant MJ, Belch AR, Pilarski LM. Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma. Blood. 2005 Jun 15;105(12):4836-44.
10. Adamia S, Treon SP, Reiman T, Tournilhac O, McQuarrie C, Mant MJ, Belch AR, Pilarski LM. Potential impact of a single nucleotide polymorphism in the hyaluronan synthase 1 gene in Waldenstrom's macroglobulinemia. Clin Lymphoma. 2005 Mar; 5(4):253-6.
11. Arizmendi-Puga NG, Enciso JA, Ortega-Pierres G, Zhao Z, Duszyk M, Ulanova M, Befus AD, Yepez-Mulia L. (2006) Trichinella spiralis: histamine secretion induced by TSL-1 antigens from unsensitized mast cells. Exp Parasitol. 2006 Oct;114(2):67-76.
12. Baber RA, Bedford RB, Betham M, Blake ME, Coles SJ, Haddow MF, Hursthouse MB, Orpen AG, Pilarski LT, Pringle PG, Wingad RL. Chiral palladium bis(phosphite)PCP-pincer complexes via ligand C-H activation. Chem Commun (Camb). 2006 Oct 1;(37):3880-2.
13. Baldwin SA, Yao SY, Hyde RJ, Ng AM, Foppolo S, Barnes K, Ritzel MW, Cass CE, Young JD. (2005) Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. J Biol Chem. 2005 Apr 22;280(16):15880-7.
14. Barnes K, Dobrzynski H, Foppolo S, Beal PR, Ismat F, Scullion ER, Sun L, Tellez J, Ritzel MW, Claycomb WC, Cass CE, Young JD, Billeter-Clark R, Boyett MR, Baldwin SA. Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH. Circ Res. 2006 Sep 1;99(5):510-9.
15. Baudet ML, Martin B, Hassanali Z, Parker E, Sanders EJ, Harvey S. (2007) Expression, translation, and localization of a novel, small growth hormone variant. Endocrinology. 2007 Jan;148(1):103-15.
16. Bernstein NK, Williams RS, Rakovszky ML, Cui D, Green R, Karimi-Busheri F, Mani RS, Galicia S, Koch CA, Cass CE, Durocher D, Weinfeld M, Glover JN. The molecular architecture of the mammalian DNA repair enzyme, polynucleotide kinase. Mol Cell. 2005 Mar 4;17(5):657-70.
17. Boisvert FM, Hendzel MJ, Masson JY, Richard S. Methylation of MRE11 regulates its nuclear compartmentalization. Cell Cycle. 2005 Jul;4(7):981-9.
18. Burnham CA, Shokoples SE, Tyrrell GJ. Phosphoglycerate kinase inhibits epithelial cell invasion by group B streptococci. Microb Pathog. 2005 May-Jun;38(5-6):189-200.
19. Carmichael JB, Stoica C, Parker H, McCaffery JM, Simmonds AJ, Hobman TC. (2006) RNA interference effector proteins localize to mobile cytoplasmic puncta in Schizosaccharomyces pombe. Traffic. 2006 Aug;7(8):1032-44.
20. Carrero G, Hendzel MJ, de Vries G. Modelling the compartmentalization of splicing factors. J Theor Biol. 2006 Apr 7;239(3):298-312.
21. Chun J, Chau AS, Maingat FG, Edmonds SD, Ostergaard HL, Shibuya EK. (2005) Phosphorylation of Cdc25C by pp90Rsk contributes to a G2 cell cycle arrest in Xenopus cycling egg extracts. Cell Cycle. 2005 Jan;4(1):148-54.
22. Clarke ML, Damaraju VL, Zhang J, Mowles D, Tackaberry T, Lang T, Smith KM, Young JD, Tomkinson B, Cass CE. (2006) The role of human nucleoside transporters in cellular uptake of 4'-thio-beta-D-arabinofuranosylcytosine and beta-D-arabinosylcytosine. Mol Pharmacol. 2006 Jul;70(1):303-10.
23. Conn KL, Hendzel MJ, Schang LM. (2008) Linker histones are mobilized during infection with herpes simplex virus type 1. J Virol. 2008 Sep;82(17):8629-46. PMID: 18579611
24. Corry GN, Hendzel MJ, Underhill DA. (2008)Subnuclear localization and mobility are key indicators of PAX3 dysfunction in Waardenburg syndrome. Hum Mol Genet. 17(12):1825-37. PMID: 18325909
25. Corry GN, Underhill DA. Pax3 target gene recognition occurs through distinct modes that are differentially affected by disease-associated mutations. Pigment Cell Res. 2005 Dec;18(6):427-38.
26. Corry GN, Underhill DA. Subnuclear compartmentalization of sequence-specific transcription factors and regulation of eukaryotic gene expression. Biochem Cell Biol. 2005 Aug;83(4):535-47.
27. Dabbagh L, Coupland RW, Cass CE, Mackey JR.(2003) Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers. Clin Cancer Res. 2003 Aug 1;9(8):3213-4. No abstract available.
28. Damaraju S, Murray D, Dufour J, Carandang D, Myrehaug S, Fallone G, Field C, Greiner R, Hanson J, Cass CE, Parliament M. (2006) Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. Clin Cancer Res. 2006 Apr 15;12(8):2545-54.
29. Damaraju S, Zhang J, Visser F, Tackaberry T, Dufour J, Smith KM, Slugoski M, Ritzel MW, Baldwin SA, Young JD, Cass CE. (2005) Identification and functional characterization of variants in human concentrative nucleoside transporter 3, hCNT3 (SLC28A3), arising from single nucleotide polymorphisms in coding regions of the hCNT3 gene. Pharmacogenet Genomics. 2005 Mar;15(3):173-82.
30. Damaraju VL, Damaraju S, Young JD, Baldwin SA, Mackey J, Sawyer MB, Cass CE. (2003) Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy. Oncogene. 2003 Oct 20;22(47):7524-36.
31. Damaraju VL, Hamilton KF, Seth-Smith ML, Cass CE, Sawyer MB. (2005) Characterization of binding of folates and antifolates to brush-border membrane vesicles isolated from human kidney. Mol Pharmacol. 2005 Feb;67(2):453-9.
32. Damaraju VL, Visser F, Zhang J, Mowles D, Ng AM, Young JD, Jayaram HN, Cass CE. (2005) Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide riboside. Mol Pharmacol. 2005 Jan;67(1):273-9.
33. David J. Shields, Susanne Lingrell, Luis B. Agellon, John T. Brosnan and Dennis E. Vance (2005) Localization-independent Regulation of Homocysteine Secretion by Phosphatidylethanolamine N-Methyltransferase. THE JOURNAL OF BIOLOGICAL CHEMISTRY 280(29)27339–27344
34. Duta F, Ulanova M, Seidel D, Puttagunta L, Musat-Marcu S, Harrod KS, Schreiber AD, Steinhoff U, Befus AD. (2006) Differential expression of spleen tyrosine kinase Syk isoforms in tissues: Effects of the microbial flora. Histochem Cell Biol. 2006 Oct;126(4):495-505.
35. Elwi AN, Damaraju VL, Baldwin SA, Young JD, Sawyer MB, Cass CE. (2006) Renal nucleoside transporters: physiological and clinical implications. Biochem Cell Biol. 2006 Dec;84(6):844-58.
36. Gagne JP, Bonicalzi ME, Gagne P, Ouellet ME, Hendzel MJ, Poirier GG. Poly(ADP-ribose) glycohydrolase is a component of the FMRP-associated messenger ribonucleoparticles. Biochem J. 2005 Dec 15;392(Pt 3):499-509.
37. Gagné JP, Hendzel MJ, Droit A, Poirier GG. (2006) The expanding role of poly(ADP-ribose) metabolism: current challenges and new perspectives. Curr Opin Cell Biol. 18(2):145-51. PMID: 16516457
38. Gaillard F, Bonfield S, Gilmour GS, Kuny S, Mema SC, Martin BT, Smale L, Crowder N, Stell WK, Sauvé Y. (2008) Retinal anatomy and visual performance in a diurnal cone-rich laboratory rodent, the Nile grass rat (Arvicanthis niloticus). The Journal of Comparative Neurology 510:525-538 (2008)
39. Gieni RS, Chan GK, Hendzel MJ. (2008) Epigenetics regulate centromere formation and kinetochore function. J Cell Biochem. 2008 Aug 15;104(6):2027-39. PMID: 18404676
40. Gieni RS, Hendzel MJ. (2008) Mechanotransduction from the ECM to the genome: are the pieces now in place? J Cell Biochem. 104(6):1964-87. PMID: 17546585
41. Goping IS, Sawchuk T, Underhill DA, Bleackley RC. Identification of {alpha}-tubulin as a granzyme B substrate during CTL-mediated apoptosis. J Cell Sci. 2006 Mar 1;119 (Pt 5):858-65.
42. Haince JF, Kozlov S, Dawson VL, Dawson TM, Hendzel MJ, Lavin MF, Poirier GG. (2007) Ataxia telangiectasia mutated (ATM) signaling network is modulated by a novel poly(ADP-ribose)-dependent pathway in the early response to DNA-damaging agents. J Biol Chem. 282(22):16441-53. PMID: 17428792
43. Haince JF, McDonald D, Rodrigue A, Déry U, Masson JY, Hendzel MJ, Poirier GG. (2008) PARP1-dependent kinetics of recruitment of MRE11 and NBS1 proteins to multiple DNA damage sites. J Biol Chem. 283(2):1197-208. Epub 2007 Nov 19. PMID: 18025084
44. Haince JF, Ouellet ME, McDonald D, Hendzel MJ, Poirier GG. (2006) Dynamic relocation of poly(ADP-ribose) glycohydrolase isoforms during radiation-induced DNA damage. Biochim Biophys Acta. 1763(2):226-37.
45. Haince JF, Rouleau M, Hendzel MJ, Masson JY, Poirier GG. Targeting poly(ADP-ribosyl)ation: a promising approach in cancer therapy. Trends Mol Med. 2005 Oct;11(10):456-63. .
46. Harvey S, Baudet ML, Sanders EJ. Growth hormone and cell survival in the neural retina: caspase dependence and independence. Neuroreport. 2006 Nov 6;17(16):1715-8.
47. Harvey S, Baudet ML, Sanders EJ. Retinal growth hormone in perinatal and adult rats. J Mol Neurosci. 2006; 28(3):257-64.
48. Harvey S, Martin BT, Baudet ML, Davis P, Sauve Y, Sanders EJ.(2007) Growth hormone in the visual system: Comparative endocrinology. Gen Comp Endocrinol. 2007 Jan 11; [Epub ahead of print]
49. Heit R, Underhill DA, Chan G, Hendzel MJ. (2006) Epigenetic regulation of centromere formation and kinetochore function. Biochem Cell Biol. 84(4):605-18. PMID: 16936832
50. Helen Everett and Grant McFadden (2001) Viral proteins and the mitochondrial apoptotic checkpoint Cytokine & Growth Factor Reviews 12 (2001) 181–188
51. Holly A. Saffran, Justin M. Pare1, Jennifer A. Corcoran, Sandra K. Weller & James R. Smiley (2007) Herpes simplex virus eliminates host mitochondrial DNA EMBO report 8(2):188-93.
52. Houston SI, McManus KJ, Adams MM, Sims JK, Carpenter PB, Hendzel MJ, Rice JC. (2008) Catalytic function of the PR-Set7 histone H4 lysine 20 monomethyltransferase is essential for mitotic entry and genomic stability. J Biol Chem. 283(28):19478-88. PMID: 18480059
53. Hussain AM, Zhang QX, Murray AG. Endothelial cell calpain activity facilitates lymphocyte diapedesis. Am J Transplant. 2005 Nov;5(11):2640-8.
54. Ing Swie Goping, Tracy Sawchuk, Aja Rieger, Irene Shostak and R. Chris Bleackley (2008) Cytotoxic T lymphocytes overcome Bcl-2 inhibition: target cells contribute to their own demise BLOOD, 111(4):?????
55. Ismail IH, Hendzel MJ. (2008) The gamma-H2A.X: is it just a surrogate marker of double-strand breaks or much more? Environ Mol Mutagen. 49(1):73-82. Review. PMID: 18095327
56. J Kirshner, KJ Thulien, LD Martin, C Debes Marun, T Reiman, AR Belch, LM Pilarski (2008) A Unique 3-D Model for Evaluating the Impact of Therapy on Multiple Myeloma Blood: Journal of the American Society for Hematology, 2008 Jun 5 [Epub ahead of print]
57. James Zan Xing, Lijun Zhu, Jo Ann Jackson, Stephan Gabos, Xue-Jun Sun, Xiao-bo Wang, and Xiao Xu (2005) Dynamic Monitoring of Cytotoxicity on Microelectronic Sensors Chem. Res. Toxicol. 18:154-161
58. Jianxun Han, Michael J. Hendzel1 and Joan Allalunis-Turner (2006) Quantitative Analysis Reveals Asynchronous and more than DSB-Associated Histone H2AX Phosphorylation after Exposure to Ionizing Radiation RADIATION RESEARCH 165, 283–292 (2006)
59. Jin-Shu He and Hanne L. Ostergaard (2007) CTLs Contain and Use Intracellular Stores of FasL Distinct from Cytolytic Granules1 J Immunol. 179(4):2339-48.
60. Julia Kirshner, Kyle J. Thulien, Lorri D. Martin, Carina Debes Marun, Tony Reiman, Andrew R. Belch, and Linda M. Pilarski (2008) Aunique three-dimensional model for evaluating the impact of therapy on multiple myeloma. BLOOD 112(7):????
61. Kaigala GV, Huskins RJ, Preiksaitis J, Pang XL, Pilarski LM, Backhouse CJ. Automated screening using microfluidic chip-based PCR and product detection to assess risk of BK virus-associated nephropathy in renal transplant recipients. Electrophoresis. 2006 Oct;27(19):3753-63.
62. Karten B, Campenot RB, Vance DE, Vance JE. (2006) Expression of ABCG1, but not ABCA1, correlates with cholesterol release by cerebellar astroglia. Biol Chem. 2006 Feb 17;281(7):4049-57.
63. Karten B, Campenot RB, Vance DE, Vance JE. (2006) The Niemann-Pick C1 protein in recycling endosomes of presynaptic nerve terminals. J Lipid Res. 2006 Mar;47(3):504-14.
64. Katyal, S., Gao, Z., Monckton, E.A., Glubrecht, D.D. and Godbout, R. (2007) The hierarchical nature of Dab1 tyrosine phosphorylation specifies Src-family kinase activation and neuritogenesis. J. Mol. Biol. 368: 349-364 (2007).
65. Keats JJ, Maxwell CA, Taylor BJ, Hendzel MJ, Chesi M, Bergsagel PL, Larratt LM, Mant MJ, Reiman T, Belch AR, Pilarski LM. Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients. Blood. 2005 May 15;105(10):4060-9. Epub 2005 Jan 27
66. Keats JJ, Reiman T, Belch AR, Pilarski LM. Ten years and counting: so what do we know about t(4;14)(p16;q32) multiple myeloma. Leuk Lymphoma. 2006 Nov; 47(11):2289-300.
67. King AE, Ackley MA, Cass CE, Young JD, Baldwin SA. Nucleoside transporters: from scavengers to novel therapeutic targets. Trends Pharmacol Sci. 2006 Aug;27(8):416-25.
68. King KM, Damaraju VL, Vickers MF, Yao SY, Lang T, Tackaberry TE, Mowles DA, Ng AM, Young JD, Cass CE. (2006) A comparison of the transportability, and its role in cytotoxicity, of clofarabine, cladribine, and fludarabine by recombinant human nucleoside transporters produced in three model expression systems. Mol Pharmacol. 2006 Jan;69(1):346-53.
69. Kriangkum J, Taylor BJ, Reiman T, Belch AR, Pilarski LM. Origins of Waldenstrom's macroglobulinemia: does it arise from an unusual B-cell precursor? Clin Lymphoma. 2005 Mar;5 (4):217-9. .
70. Kriangkum J, Taylor BJ, Strachan E, Mant MJ, Reiman T, Belch AR, Pilarski LM. Impaired class switch recombination (CSR) in Waldenstrom macroglobulinemia (WM) despite apparently normal CSR machinery. Blood. 2006 Apr 1;107(7):2920-7.
71. Leslie A Hayduk at. al. (Greta cummings, Nursing school), 2005 BMC medical research methodology 5:1-9
72. Li, L., Monckton, E.A. and Godbout, R. (2008) A role for DEAD box 1 at DNA double-strand breaks.Mol. Cell. Biol. 28: 6413-6425.
73. Li, L., Roy, K., Katyal, S., Sun, X., Bleoo, S. and Godbout, R. (2006) Dynamic nature of cleavage bodies and their spatial relationship to DDX1 bodies, Cajal bodies and gems. Mol. Biol. Cell. 17: 1126-1140.
74. Li. X., Glubrecht, D.D., Mita, R. and Godbout, R. (2008) Expression of AP-2d in the developing chick retina.Dev. Dyn. 237: 3210-3221.
75. Lockhart WL, Stern GA, Low G, Hendzel M, Boila G, Roach P, Evans MS, Billeck BN, DeLaronde J, Friesen S, Kidd K, Atkins S, Muir DC, Stoddart M, Stephens G, Stephenson S, Harbicht S, Snowshoe N, Grey B, Thompson S, DeGraff N. A history of total mercury in edible muscle of fish from lakes in northern Canada. Sci Total Environ. 2005 Dec 1;351-352:427-63.
76. Lucila Saavedra, Amany Mohamed, Victoria Ma, Satyabrata Kar¶, and Elena Posse de Chaves (2007) Internalization of _-Amyloid Peptide by Primary Neurons in the Absence of Apolipoprotein ETHE JOURNAL OF BIOLOGICAL CHEMISTRY282(49):35722–35732
77. Lysechko TL, Ostergaard HL. (2005) Differential Src family kinase activity requirements for CD3 zeta phosphorylation/ZAP70 recruitment and CD3 epsilon phosphorylation. J Immunol. 2005 Jun 15;174(12):7807-14.
78. Mackey JR, Baldwin SA, Young JD, Cass CE. Nucleoside transport and its significance for anticancer drug resistance. Drug Resist Updat. 1998 Oct;1(5):310-24.
79. Mackey JR, Galmarini CM, Graham KA, Joy AA, Delmer A, Dabbagh L, Glubrecht D, Jewell LD, Lai R, Lang T, Hanson J, Young JD, Merle-Beral H, Binet JL, Cass CE, Dumontet C. (2005) Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations. Blood. 2005 Jan 15;105(2):767-74.
80. Maxwell CA, Keats JJ, Belch AR, Pilarski LM, Reiman T. Receptor for hyaluronan-mediated motility correlates with centrosome abnormalities in multiple myeloma and maintains mitotic integrity. Cancer Res. 2005 Feb 1;65(3):850-60.
81. Maxwell CA, Pilarski LM. A potential role for centrosomal deregulation within IgH translocation-positive myeloma. Med Hypotheses. 2005;65(5):915-21.
82. McCauley SD, Gilchrist M, Befus AD. (2005) Nitric oxide: a major determinant of mast cell phenotype and function. Mem Inst Oswaldo Cruz. 2005 Mar;100 Suppl 1:11-4.
83. McCauley SD, Gilchrist M, Befus AD. (2007) Regulation and function of the protein inhibitor of nitric oxide synthase (PIN)/dynein light chain 8 (LC8) in a human mast cell line. Life Sci. 2007 Feb 13;80(10):959-64.
84. McDonald D, Carrero G, Andrin C, de Vries G, Hendzel MJ. (2006)Nucleoplasmic beta-actin exists in a dynamic equilibrium between low-mobility polymeric species and rapidly diffusing populations. J Cell Biol.172(4):541-52. PMID: 16476775
85. McManus KJ, Biron VL, Heit R, Underhill DA, Hendzel MJ Dynamic changes in histone H3 lysine 9 methylations: identification of a mitosis-specific function for dynamic methylation in chromosome congression and segregation. J Biol Chem. 2006 Mar 31;281(13):8888-97. Erratum in: J Biol Chem. 2006 Dec 15;281(50):38966. dosage error in text.
86. McManus KJ, Hendzel MJ. (2006) The relationship between histone H3 phosphorylation and acetylation throughout the mammalian cell cycle. Biochem Cell Biol. 84(4):640-57. .
87. McManus KJ, Hendzel MJ. ATM-dependent DNA damage-independent mitotic phosphorylation of H2AX in normally growing mammalian cells. Mol Biol Cell. 2005 Oct;16(10):5013-25.
88. McManus KJ, Hendzel MJ. Using quantitative imaging microscopy to define the target substrate specificities of histone post-translational-modifying enzymes. Methods. 2005 Aug;36(4):351-61.
89. McManus KJ, Stephens DA, Adams NM, Islam SA, Freemont PS, Hendzel MJ. (2006) The transcriptional regulator CBP has defined spatial associations within interphase nuclei. PLoS Comput Biol. 2(10):e139. PMID: 17054391
90. Meaghan H. Hancock, Jennifer A. Corcoran, James R. Smiley (2006) Herpes simplex virus regulatory proteins VP16 and ICP0 counteract an innate intranuclear barrier to viral gene expression Virology 352 (2006) 237–252
91. Mei He Yong Zeng Xuejun Sun D. Jed Harrison (2008)Confinement effects on the morphology of photopatterned porous polymer monoliths for capillary and microchip electrophoresis of proteins Electrophoresis 29, 2980–2986
92. Mirzayans R, Scott A, Cameron M, Murray D. (2005) Induction of accelerated senescence by gamma radiation in human solid tumor-derived cell lines expressing wild-type TP53. Radiat Res. 2005 Jan;163(1):53-62.
93. Mirzayans R, Severin D, Murray D. (2006) Relationship between DNA double-strand break rejoining and cell survival after exposure to ionizing radiation in human fibroblast strains with differing ATM/p53 status: implications for evaluation of clinical radiosensitivity. Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1498-505.
94. Mita, R. Coles, J.E., Glubrecht, D., Sung, R. Sun, X. and Godbout, R. (2007) B-FABP-expressing radial glial cells – the malignant glioma cell-of-origin? Neoplasia 9: 734-744.
95. M-L Baudet, B. Martin, Z. Hassanali, E. Parker, E.J. Sanders and S. HarveyExpression, translation and localization of a novel, small growth hormone variant ????????
96. Moore, Ronald, et al.(2008) Photodynamic therapy of the canine prostate: intra-arterial drug delivery.Cardiovasc Intervent Radiol31:164-176.
97. Nick van Buuren, Brianne Couturier, Yue Xiong, and Michele Barry (2008) Ectromelia Virus Encodes a Novel Family of F-Box Proteins That Interact with the SCF Complex. JOURNAL OF VIROLOGY, 82(20):9917–9927
98. Osman MS, Burshtyn DN, Kane KP. Activating Ly-49 receptors regulate LFA-1-mediated adhesion by NK cells. J Immunol. 2007 Feb 1;178(3):1261-7.
99. Pilarski LM, Lauzon J, Strachan E, Adamia S, Atrazhev A, Belch AR, Backhouse CJ. Sensitive detection using microfluidics technology of single cell PCR products from high and low abundance IgH VDJ templates in multiple myeloma. J Immunol Methods. 2005 Oct 20;305(1):94-105.
100. Puente LG, He JS, Ostergaard HL. (2006) A novel PKC regulates ERK activation and degranulation of cytotoxic T lymphocytes: Plasticity in PKC regulation of ERK. Eur J Immunol. 2006 Apr;36(4):1009-18.
101. Puente LG, Mireau LR, Lysechko TL, Ostergaard HL. (2005) Phosphatidylinositol-3-kinase regulates PKCtheta activity in cytotoxic T cells. Mol Immunol. 2005 Jun;42(10):1177-84.
102. Redzic ZB, Biringer J, Barnes K, Baldwin SA, Al-Sarraf H, Nicola PA, Young JD, Cass CE, Barrand MA, Hladky SB. (2005) Polarized distribution of nucleoside transporters in rat brain endothelial and choroid plexus epithelial cells. J Neurochem. 2005 Sep;94(5):1420-6.
103. Rene L. Jacobs, Susanne Lingrell, Yang Zhao, Gordon A. Francis, and Dennis E. Vance (2008)Hepatic CTP:Phosphocholine Cytidylyltransferase-_ Is a Critical Predictor of Plasma High Density Lipoprotein and Very Low Density Lipoprotein.THE JOURNAL OF BIOLOGICAL CHEMISTRY 283(4) 2147–2155
104. Rezania V, Tuszynski J, Hendzel M. (2007) Modeling transcription factor binding events to DNA using a random walker/jumper representation on a 1D/2D lattice with different affinity sites. Phys Biol. 4(4):256-67. PMID: 18185004
105. Roa W, Chen H, Th’ng J, Sun XJ, Petruk K, Moore R., (2005) Enhancement of Radiation Sensitivity with BH3I-1 in Non-small Cell Lung Cancer. Clin Invest. Med. 28(2):55-63.
106. Robertson LK, Mireau LR, Ostergaard HL. (2005) A role for phosphatidylinositol 3-kinase in TCR-stimulated ERK activation leading to paxillin phosphorylation and CTL degranulation. J Immunol. 2005 Dec 15;175(12):8138-45.
107. Rodrigue A, Lafrance M, Gauthier MC, McDonald D, Hendzel M, West SC, Jasin M, Masson JY. Interplay between human DNA repair proteins at a unique double-strand break in vivo. EMBO J. 2006 Jan 11;25(1):222-31.
108. Rouleau M, McDonald D, Gagne P, Ouellet ME, Droit A, Hunter JM, Dutertre S, Prigent C, Hendzel MJ, Poirier GG. PARP-3 associates with polycomb group bodies and with components of the DNA damage repair machinery. J Cell Biochem. 2007 Feb 1;100(2):385-401.
109. Sarkar M, Han T, Damaraju V, Carpenter P, Cass CE, Agarwal RP. (2005) Cytosine arabinoside affects multiple cellular factors and induces drug resistance in human lymphoid cells. Biochem Pharmacol. 2005 Aug 1;70(3):426-32.
110. Scott RJ, Lusk CP, Dilworth DJ, Aitchison JD, Wozniak RW. Interactions between Mad1p and the nuclear transport machinery in the yeast Saccharomyces cerevisiae. Mol Biol Cell. 2005 Sep;16(9):4362-74.
111. Sengoelge G, Luo W, Fine D, Perschl AM, Fierlbeck W, Haririan A, Sorensson J, Rehman TU, Hauser P, Trevick JS, Kulak SC, Wegner B, Ballermann BJ. LinksA SAGE-based comparison between glomerular and aortic endothelial cells. Am J Physiol Renal Physiol. 2005 Jun;288(6):F1290-300.
112. Shen A, Puente LG, Ostergaard HL. (2005) Tyrosine kinase activity and remodelling of the actin cytoskeleton are co-temporally required for degranulation by cytotoxic T lymphocytes. Immunology. 2005 Oct;116(2):276-86.
113. Shen Q, Rahn JJ, Zhang J, Gunasekera N, Sun X, Shaw AR, Hendzel MJ, Hoffman P, Bernier A, Hugh JC. (2008) MUC1 initiates Src-CrkL-Rac1/Cdc42-mediated actin cytoskeletal protrusive motility after ligating intercellular adhesion molecule-1. Mol Cancer Res. 6(4):555-67. PMID: 18403635
114. Shi Y, Reiman T, Li W, Maxwell CA, Sen S, Pilarski L, Daniels TR, Penichet ML, Feldman R, Lichtenstein A. Targeting aurora kinases as therapy in multiple myeloma. Blood. 2007 Jan 9;
115. Sipione S, Ewen C, Shostak I, Michalak M, Bleackley RC. (2005) Impaired cytolytic activity in calreticulin-deficient CTLs. J Immunol. 2005 Mar 15;174(6):3212-9.
116. Sipione S, Simmen KC, Lord SJ, Motyka B, Ewen C, Shostak I, Rayat GR, Dufour JM, Korbutt GS, Rajotte RV, Bleackley RC. (2006) Identification of a novel human granzyme B inhibitor secreted by cultured sertoli cells. J Immunol. 2006 Oct 15;177(8):5051-8.
117. Smith KM, Slugoski MD, Loewen SK, Ng AM, Yao SY, Chen XZ, Karpinski E, Cass CE, Baldwin SA, Young JD. (2005) The broadly selective human Na+/nucleoside cotransporter (hCNT3) exhibits novel cation-coupled nucleoside transport characteristics. J Biol Chem. 2005 Jul 8;280(27):25436-49.
118. Steenbergen R, Nanowski TS, Beigneux A, Kulinski A, Young SG, Vance JE. (2005) Disruption of the phosphatidylserine decarboxylase gene in mice causes embryonic lethality and mitochondrial defects. J Biol Chem. 2005 Dec 2;280(48):40032-40.
119. Steenbergen R, Nanowski TS, Nelson R, Young SG, Vance JE. (2006) Phospholipid homeostasis in phosphatidylserine synthase-2-deficient mice. Biochim Biophys Acta. 2006 Mar;1761(3):313-23.
120. Steve Harvey, Brent T. Martin, Marie-Laure Baudet, Phil Davis, Yves Sauve, Esmond J. Sanders Growth hormone in the visual system: Comparative endocrinology ?????????
121. Stewart TL, Wasilenko ST, Barry M. (2005)Vaccinia virus F1L protein is a tail-anchored protein that functions at the mitochondria to inhibit apoptosis. J Virol. 2005 Jan;79(2):1084-98.
122. Sun, Bo, et al. Response of bladder carcinoma cells to TRAIL and Anti-sense oligonucleotide- Bcl2 or Clusterin treatments. J Urol (in press)
123. Tara M Tancred, Andrew R Belch, Tony Reiman, Linda M Pilarski, and Julia Kirshner.(2008) Altered Expression of Fibronectin and Collagens I and IV in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance(in press) Journal of Histochemistry and Cytochemistry
124. Taylor BJ, Kriangkum J, Strachan ER, Wizniak J, Pilarski LM. Identification of clonotypic IgH VDJ sequences in multiple myeloma. Methods Mol Med. 2005;113:121-44.
125. Taylor BJ, Reiman T, Pittman JA, Keats JJ, de Bruijn DR, Mant MJ, Belch AR, Pilarski LM. SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCs. J Immunother. 2005 Nov-Dec;28(6):564-75.
126. Taylor JM, Barry M. (2006) Near death experiences: poxvirus regulation of apoptotic death. Virology. 5;344(1):139-50.
127. Taylor JM, Quilty D, Banadyga L, Barry M. The vaccinia virus protein F1L interacts with Bim and inhibits activation of the pro-apoptotic protein Bax. J Biol Chem. 2006 Dec 22;281(51):39728-39.
128. Taylor JM, Quilty D, Banadyga L, Barry M.(2006) The vaccinia virus protein F1L interacts with Bim and inhibits activation of the pro-apoptotic protein Bax. J Biol Chem. 2006 Dec 22;281(51):39728-39.
129. Th'ng JP, Sung R, Ye M, Hendzel MJ. H1 family histones in the nucleus. Control of binding and localization by the C-terminal domain. J Biol Chem. 2005 Jul 29;280(30):27809-14.
130. Ulanova M, Duta F, Puttagunta L, Schreiber AD, Befus AD. (2006) Spleen tyrosine kinase (Syk) as a novel target for allergic asthma and rhinitis. Expert Opin Ther Targets. 2005 Oct;9(5):901-21.
131. Ulanova M, Marcet-Palacios M, Munoz S, Asfaha S, Kim MK, Schreiber AD, Befus AD. (2006) Involvement of Syk kinase in TNF-induced nitric oxide production by airway epithelial cells. Biochem Biophys Res Commun. 2006 Dec 15;351(2):431-7.
132. Ulanova M, Puttagunta L, Marcet-Palacios M, Duszyk M, Steinhoff U, Duta F, Kim MK, Indik ZK, Schreiber AD, Befus AD. (2005) Syk tyrosine kinase participates in beta1-integrin signaling and inflammatory responses in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2005 Mar;288(3):L497-507.
133. Ulanova M, Schreiber AD, Befus AD. (2006) The future of antisense oligonucleotides in the treatment of respiratory diseases. BioDrugs. 2006;20(1):1-11.
134. Vance JE, Steenbergen R. (2005) Metabolism and functions of phosphatidylserine. Prog Lipid Res. 2005 Jul;44(4):207-34.
135. Veugelers K, Motyka B, Goping IS, Shostak I, Sawchuk T, Bleackley RC. (2006) Granule-mediated killing by granzyme B and perforin requires a mannose 6-phosphate receptor and is augmented by cell surface heparan sulfate. Mol Biol Cell. 2006 Feb;17(2):623-33.
136. Visser F, Baldwin SA, Isaac RE, Young JD, Cass CE. (2005) Identification and mutational analysis of amino acid residues involved in dipyridamole interactions with human and Caenorhabditis elegans equilibrative nucleoside transporters. J Biol Chem. 2005 Mar 25;280(12):11025-34.
137. Visser F, Zhang J, Raborn RT, Baldwin SA, Young JD, Cass CE. (2005) Residue 33 of human equilibrative nucleoside transporter 2 is a functionally important component of both the dipyridamole and nucleoside binding sites. Mol Pharmacol. 2005 Apr;67(4):1291-8.
138. Wang JF, Jiao H, Stewart TL, Shankowsky HA, Scott PG, Tredget EE. Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Repair Regen. 2007 Jan-Feb;15(1):113-21.
139. Wasilenko ST, Banadyga L, Bond D, Barry M. (2005)The vaccinia virus F1L protein interacts with the proapoptotic protein Bak and inhibits Bak activation. J Virol. 2005 Nov;79(22):14031-43.
140. Xiao, Zhengwen, et al. (2007) Fractionated versus standard continuous light delivery in interstitial photodynamic therapy of Dunning prostate carcinomas. Clin Cancer Res13:7496-7505.
141. Xing JZ, Zhu L, Jackson JA, 20 Gabos S, Sun XJ, Wang XB, Xu X. (2005) Dynamic monitoring of cytotoxicity on microelectronic sensors. Chem. Res. Toxicol. 18(2):154-61.
142. Zhang J, Smith KM, Tackaberry T, Visser F, Robins MJ, Nielsen LP, Nowak I, Karpinski E, Baldwin SA, Young JD, Cass CE. (2005) Uridine binding and transportability determinants of human concentrative nucleoside transporters. Mol Pharmacol. 2005 Sep;68(3):830-9.
143. Zhang J, Sun XJ, Smith KM, Carpenter P., Barron G., Peng YS, Robins MJ, Baldwin SA, Young JD, and Cass CE. (2006) Studies of Nucleoside Transporters Using Autofluorescent Nucleoside Analogues. Biochemistry. 2006 Jan 31;45(4):1087-98.
144. Zhang J, Tackaberry T, Ritzel MW, Raborn T, Barron G, Baldwin SA, Young JD, Cass CE. (2006) Cysteine-accessibility analysis of transmembrane domains 11-13 of human concentrative nucleoside transporter 3. Biochem J. 2006 Mar 1;394(Pt 2):389-98.
145. Zhang J, Visser F, King KM, Baldwin SA, Young JD, Cass CE. (2007) The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs. Cancer Metastasis Rev. 2007 Mar 8.